Tech Tour Growth Health is one of Europe’s most established gatherings at the intersection of healthcare innovation and investment –
Volv Global is pleased to be participating in the Life Sciences Innovation & Investment Corridor between Lausanne & London, hosted
The idea that an AI system could detect a disease that appears nowhere in a patient’s medical record sounds like
The ISPOR International Annual Conference 2026 brings together global leaders in health economics and outcomes research to explore the
Inflammatory Bowel Disease (IBD) management has evolved significantly with advanced therapies and data-driven care strategies. Yet, one persistent issue continues
Introduction Advocacy plays a critical role in accelerating progress in rare diseases. As technology advances, collaboration between patient communities, researchers,
As our commemoration of Rare Disease Day 2026, we are pleased to present a guest article by Jessica Lynn at
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction Earlier cancer detection remains one of the most powerful opportunities
Finding the Patients We’re Missing Rare diseases often remain undiagnosed for years, leaving patients without timely treatment and care. Despite
Introduction Volv Global participation in Faces of Industrial Research 2026 reflects its commitment to connecting scientific innovation with real-world healthcare
In 2024, Sanofi – working in partnership with The BMJ – released the Rairity: Air Time For Rare Diseases podcast
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction: COPD as a “Syndrome,” Not Just One Disease Chronic
